Alpha-1 antitrypsin deficiency is a rare inherited condition that predisposes affected individuals to early onset lung and liver disorders. Importantly, early intervention may have major impact upon disease presentations. The Ohio State alpha-1 clinic seeks to counsel individuals with a new diagnosis of alpha-1 antitrypsin deficiency. We have over 25 years experience focusing upon this disorder. Our clinic offers counseling regarding genetic transmission and provides state of the art evaluations to determine extent, if any, of lung involvement. We pay particular attention to long term management and provide advice for decisions regarding institution of augmentation therapy (i.e. replacing alpha-1 antitrypsin levels by weekly infusions) and health measures to prevent future loss of lung function.
For more information on Alpha-1 antitrypsin deficiency, including educational material, visit the Alpha-1 Foundation website.
|Dr. Mark Wewers is a nationally recognized expert in alpha-1 antitrypsin deficiency. He is recognized by the Alpha-1 Foundation in running the Clinical Resource Center at OSU. It is only one of four centers in the state of Ohio that specialize in this disorder.|